Sun Pharmaceutical Industries Share Price Today - Live Blog for July 23, 2025

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.29%, with its current market value per share resting at ₹1,686.00. This development highlights the stock's appeal to investors.

After a notable 0.03% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,682.55. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.04% drop, and it's now trading at ₹1,680.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,681.15 per share.

Sun Pharmaceutical Industries Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,680.00. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Demonstrating a commendable 0.10% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,681.60. In terms of valuation, the stock maintains a PE ratio of 36.8400, while the industry PE ratio stands at 35.8055.

Sun Pharmaceutical Industries Ltd witnessed a -0.00% decrease in its share price, and it is currently trading at ₹1,680.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a -0.22% decrease, reaching a current market price of ₹1,680.05. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.05% boost, with the current market value at ₹1,683.75 per share. This surge has not gone unnoticed by investors.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.26%, with the current market value at ₹1,681.65 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.06%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,686.05 per share.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.06%, with the current market value at ₹1,685.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.14% drop, and it's now trading at ₹1,686.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.20%, reaching the current market price of ₹1,687.00. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.15%, and it is currently trading at ₹1,681.60. Additionally, the stock maintains a PE ratio of 36.8400, while the industry PE is 35.8055.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.15% surge in its share price and is presently trading at ₹1,681.60. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.07% surge in its share price and is presently trading at ₹1,679.00, captivating the attention of market participants.

After a notable 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,679.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

After a -0.13% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,676.60. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.07%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,677.95, and market participants are assessing the implications. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,675.80, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,675.80, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,673.30. With the stock's PE at 36.8400 and the industry PE at 35.8055, investors are weighing their options.

With a -0.11% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,673.50. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8400, whereas the industry PE ratio stands at 35.8055.

Sun Pharmaceutical Industries Ltd observed a -0.32% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,674.25. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.48%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,679.35, and market participants are assessing the implications. The stock has a PE ratio of 36.8400, an ROE of 15.1334% and a debt to equity ratio of 0.0327.